FDA to Convene Pharmacy Compounding Advisory Committee in July Last week @fda sends out clarification on who can and cannot compound #glp1 like #tirzeaptide and #semaglutide and this week ProRx 503b shuts down GLP 1 compounding while @martymakary is photographed holding bootleg # Best Way to Take BPC 157: Dosage & Administration Industry Update: Interim 503A and 503B Bulks Lists New Revisions The FDA may be about to change everything for peptide research. Secretary RFK Jr. announced plans to move 14 peptides from Category 2 to Category 1. That means FDA recognized. Potentially prescribable through